Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Riccardo Moia, Donatella Talotta et al.|British Journal of Haematology|2022Cited by 24
Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcomeBarbara Vannata, Emanuele Zucca, Annarita Conconi et al.|British Journal of Haematology|2019Cited by 20
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trialsMassimo Gentile, Pellegrino Musto, Roberto Ria et al.|Haematologica|2023Cited by 19
Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE PlatformFabio Efficace, Marco Vignetti, Andrea Patriarca et al.|Frontiers in Oncology|2022Cited by 12
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphomaRiccardo Moia, Gianluca Gaïdano, Chiara Favini et al.|British Journal of Haematology|2021Cited by 10